Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis
Cancer Communications · 2026
DOI: 10.34133/cancomm.0049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Communications, 2026. Verfasst von Xiaoran Cui und 14 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, P. R. China. Hauptthemen laut MEDLINE: Macrophages, Immune Checkpoint Inhibitors, Pneumonia, T-Lymphocytes. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Noncommunicable Chronic Diseases-National Science and Technology Major Project, the Major Research Program of the National Health Commission.
Abstract (Originalsprache)
Background
Immune checkpoint inhibitor-mediated pneumonitis (CIP) constitutes a major toxicity that limits the clinical application of cancer immunotherapy, whereas its underlying mechanisms remain incompletely understood. Current management relies on nonspecific immunosuppressants, lacking precision therapies. Although single-cell RNA sequencing (scRNA-seq) of bronchoalveolar lavage fluid (BALF) has implicated T cell activation and inflammatory myeloid responses in CIP pathogenesis, critical gaps persist regarding interstitial lung immunity and mechanisms governing monocyte/macrophage–T cell co-enrichment and crosstalk. We aimed to delineate the lung immune circuits that drive CIP and to identify targetable monocyte/macrophage–T cell pathways that could be leveraged for precision intervention.
Methods
To elucidate CIP pathogenesis, we performed integrated scRNA-seq analysis of BALF from CIP + and CIP − patients with validation in a prospective cohort using flow cytometry, enzyme-linked immunosorbent assay, Western blotting, and quantitative polymerase chain reaction. Mechanistic studies were performed using an established tumor-bearing forkhead box P3–diphtheria toxin receptor–green fluorescent protein ( Foxp3-DTR-GFP ) mouse model of programmed death-1 inhibitor-induced CIP via micro-computed tomography, histopathology, scRNA-seq, flow cytometry, multiplex immunofluorescence, Western blotting, Transwell migration assays, and pharmacologic interventions.
Results
In CIP + patient BALF and mouse lung tissues, CD8 + T cells expressing cytotoxic effectors and C-X-C chemokine receptor 3 (CXCR3) expanded concomitantly with distinct C-C chemokine receptor 2 (CCR2) + monocyte-derived macrophages (MoMΦ) exhibiting a highly inflammatory phenotype, while tissue-resident macrophages were markedly reduced. Mouse models revealed that expanded CCR2 + MoMΦ originating from circulation replenished the depleted niche of lung-resident interstitial macrophages. Mechanistically, integrated in silico prediction and experimental validation demonstrated that CCR2 + MoMΦ recruited CD8 + T cells via the C-X-C motif chemokine ligand 9/10 (CXCL9/10)–CXCR3 axis. Conversely, CD8 + T cells drove CCR2 + MoMΦ expansion and pro-inflammatory phenotype via the interferon-γ (IFN-γ) axis, suggesting the existence of a positive feedback loop between these cell types. Pharmacological targeting of CCR2/CCR5 or CXCR3 signaling attenuated pneumonitis, reduced pulmonary CCR2 + MoMΦ infiltration, diminished pathogenic T cell activation and cytotoxicity, and improved survival without compromising antitumor immunity.
Conclusions
Our findings establish CCR2 + MoMΦ and the IFN-γ–CXCL9/10–CXCR3 axis as core drivers of CIP pathogenesis and validate their therapeutic targeting potential. This work provides a scientific foundation for developing CIP-specific prevention and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Senior Department of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.
- Institute of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.
- Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China.
- Department of Oncology, the Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P. R. China.
- Department of Oncology, the Second Medical Center of Chinese PLA General Hospital, Beijing, P. R. China.
- Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, P. R. China.
ORCID-Profile: Xiaoran Cui, Renyong Zhi, Tianyi Liu, Yi Hu
Förderung
- the Noncommunicable Chronic Diseases-National Science and Technology Major Project
- the Major Research Program of the National Health Commission
Zitieren
APA
Cui, X., Zhi, R., Li, X., Ji, Y., Hu, Z., Cui, P., Qin, Y., Li, T., Wu, L., Wang, L., Li, J., Bai, Y., Li, H., Liu, T., & Hu, Y. (2026). Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis. Cancer Communications. https://doi.org/10.34133/cancomm.0049
Vancouver
Cui X, Zhi R, Li X, Ji Y, Hu Z, Cui P, et al. Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis. Cancer Communications. 2026. doi:10.34133/cancomm.0049
BibTeX
@article{Cui2026,
author = {Cui, Xiaoran and Zhi, Renyong and Li, Xiaoyan and Ji, Yinming and Hu, Zhisong and Cui, Pengfei and Qin, Yuhui and Li, Tao and Wu, Liangliang and Wang, Lingxiong and Li, Jinfeng and Bai, Yibing and Li, Hui and Liu, Tianyi and Hu, Yi},
title = {Recruited Monocyte-Derived Macrophages Drive T Cell Inflammation in Immune Checkpoint Inhibitor-Mediated Pneumonitis},
journal = {Cancer Communications},
year = {2026},
doi = {10.34133/cancomm.0049}
}
EUVIMED